Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital... Show more
Solana Company (NASDAQ: HSDT), formerly Helius Medical Technologies, is a publicly listed digital asset infrastructure and services company. The business combines active digital asset treasury management, institutional-grade staking and validator operations, and advisory services for financial institutions navigating blockchain adoption. Its stated mission is to put more SOL behind every share, positioning the stock as a publicly traded vehicle for gaining exposure to the Solana ecosystem.
The company emerged from a transformation that began in 2025, when the former medical-device business was repositioned as a digital asset treasury in partnership with Pantera Capital and Summer Capital. HSDT holds approximately 2.3 million SOL tokens on its balance sheet and generates activity through staking yield, validator network fees, and institutional advisory work. This structure makes the stock a high-beta proxy for Solana network fundamentals and crypto market sentiment, which is why investors follow its price closely.
Over the last 30 days, HSDT has declined approximately 24%, falling from a close of about $2.94 to $2.23. The move was not linear: shares climbed to a closing peak of $3.27 on September 22 before steadily giving back those gains through October.
The pullback contrasts with the stock's performance over the last quarter. Measured from late July, when shares traded near $1.68, HSDT is still up roughly 33% despite the recent decline. That divergence underscores the volatility typical of digital asset treasury stocks, which can rally quickly on momentum and retrace just as rapidly when sentiment cools.
The 30-day decline is best understood as a retracement of the rapid September advance rather than a single company-specific setback. Because HSDT operates as a Solana treasury vehicle, its share price is heavily influenced by the SOL token and the broader digital asset market, both of which have exhibited heightened volatility during this period.
On the corporate front, Solana Company announced on October 22 that it had been designated a strategic enterprise by the Hong Kong government's Office for Attracting Strategic Enterprises (OASES), making it the only blockchain infrastructure company onboarded in 2026. The company said it would establish its Asia-Pacific headquarters in Hong Kong and deploy Solana validator nodes under its Pacific Backbone initiative. While notable, the announcement did not reverse the stock's downward drift, suggesting investors had already priced in much of the company's regional expansion narrative.
Over the last quarter, HSDT's broader trend has been positive, with shares rising roughly 33% from their late-July levels. The advance reflected growing investor interest in the company's repositioning as a Solana-focused digital asset treasury and infrastructure operator.
Key developments underpinning the quarterly move include the continued build-out of the company's validator operations, the Pacific Backbone initiative connecting financial hubs across the Asia-Pacific, and the accumulation of SOL on its balance sheet. The Hong Kong strategic enterprise designation in late October added further institutional credibility to those regional ambitions. However, the stock's sharp September spike and subsequent pullback show that much of this repricing was momentum-driven and remains sensitive to shifts in crypto market sentiment.
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots from a platform that offers hundreds of bots trading thousands of tickers. Only the top-performing and most relevant strategies appear in this section, and each bot differs in its trading strategy, timeframe, and performance metrics. The page gives investors a way to browse actively trading algorithms and review their recent results. Explore the Trending AI Robots page to see which strategies are currently in focus.
Looking ahead, the most important factor for HSDT is likely to be the price of SOL and the broader direction of the digital asset market, given the company's treasury-centric model. Investors should also monitor the rollout of the Pacific Backbone initiative, including the deployment of validator nodes in Hong Kong following the operational Tokyo cluster, and the pace at which the company's institutional advisory and staking activities translate into reported revenue.
Regulatory developments will matter as well, including Hong Kong's evolving digital asset framework and any shifts in U.S. crypto policy. Finally, the company's capital-raising activity and any changes to its SOL holdings or share count could influence the stock, since equity issuance has the potential to affect the SOL-per-share metric that underpins the investment thesis. As with any early-stage digital asset vehicle, HSDT carries meaningful volatility and execution risk.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HSDT saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 74 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HSDT turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 36 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
HSDT moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HSDT crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HSDT entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for HSDT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +3.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSDT advanced for three days, in 171 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
HSDT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. HSDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.718) is normal, around the industry mean (2.420). P/E Ratio (0.010) is within average values for comparable stocks, (-3.848). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.268) among similar stocks. P/S Ratio (11.574) is also within normal values, averaging (15.694).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a medical technology company focused on neurological wellness
Industry InvestmentManagers